These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

464 related articles for article (PubMed ID: 12578397)

  • 21. Zanamivir use during transmission of amantadine-resistant influenza A in a nursing home.
    Lee C; Loeb M; Phillips A; Nesbitt J; Smith K; Fearon M; McArthur MA; Mazzulli T; Li Y; McGeer A
    Infect Control Hosp Epidemiol; 2000 Nov; 21(11):700-4. PubMed ID: 11089653
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Antivirals for influenza in healthy adults: systematic review.
    Jefferson T; Demicheli V; Rivetti D; Jones M; Di Pietrantonj C; Rivetti A
    Lancet; 2006 Jan; 367(9507):303-13. PubMed ID: 16443037
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Antivirals for influenza: what is their role in the older patient?
    Dumyati G; Falsey AR
    Drugs Aging; 2002; 19(10):777-86. PubMed ID: 12390054
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The treatment of influenza with antiviral drugs.
    Stiver G
    CMAJ; 2003 Jan; 168(1):49-56. PubMed ID: 12515786
    [TBL] [Abstract][Full Text] [Related]  

  • 25. New approaches to influenza chemotherapy. Neuraminidase inhibitors.
    Calfee DP; Hayden FG
    Drugs; 1998 Oct; 56(4):537-53. PubMed ID: 9806102
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Antiviral treatment of influenza in humans].
    Nüesch R
    Ther Umsch; 2007 Nov; 64(11):635-41. PubMed ID: 18581908
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Amantadine, oseltamivir and zanamivir for the prophylaxis of influenza (including a review of existing guidance no. 67): a systematic review and economic evaluation.
    Tappenden P; Jackson R; Cooper K; Rees A; Simpson E; Read R; Nicholson K
    Health Technol Assess; 2009 Feb; 13(11):iii, ix-xii, 1-246. PubMed ID: 19215705
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Perspectives on antiviral use during pandemic influenza.
    Hayden FG
    Philos Trans R Soc Lond B Biol Sci; 2001 Dec; 356(1416):1877-84. PubMed ID: 11779387
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Influenza.
    Khare MD; Sharland M
    Expert Opin Pharmacother; 2000 Mar; 1(3):367-75. PubMed ID: 11249523
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Inhaled zanamivir versus placebo for the prevention of influenza outbreaks in an unvaccinated long-term care population.
    Ambrozaitis A; Gravenstein S; van Essen GA; Rubinstein E; Balciuniene L; Stikleryte A; Crawford C; Elliott M; Shult P
    J Am Med Dir Assoc; 2005; 6(6):367-74. PubMed ID: 16286057
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Influenza virus neuraminidase inhibitors.
    Gubareva LV; Kaiser L; Hayden FG
    Lancet; 2000 Mar; 355(9206):827-35. PubMed ID: 10711940
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Emergence of rimantadine-resistant virus within 6 days of starting rimantadine prophylaxis with oseltamivir treatment of symptomatic cases.
    Drinka PJ; Haupt T
    J Am Geriatr Soc; 2007 Jun; 55(6):923-6. PubMed ID: 17537095
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Oseltamivir, zanamivir and amantadine in the prevention of influenza: a systematic review.
    Jackson RJ; Cooper KL; Tappenden P; Rees A; Simpson EL; Read RC; Nicholson KG
    J Infect; 2011 Jan; 62(1):14-25. PubMed ID: 20950645
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Advances in the prophylaxis and treatment of influenza illness. Based on a presentation by Frederick G. Hayden, MD.
    Am J Manag Care; 2000 Mar; 6(5 Suppl):S247-54. PubMed ID: 10977471
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Emergence and transmission of amantadine-resistant influenza A in a nursing home.
    Schilling M; Gravenstein S; Drinka P; Cox N; Krause P; Povinelli L; Shult P
    J Am Geriatr Soc; 2004 Dec; 52(12):2069-73. PubMed ID: 15571544
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Neuraminidase inhibitors in therapy of influenza].
    Fladerer P; Wenisch C
    Acta Med Austriaca; 2000; 27(5):133-40. PubMed ID: 11261262
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Managing influenza: amantadine, rimantadine and beyond.
    Fleming DM
    Int J Clin Pract; 2001 Apr; 55(3):189-95. PubMed ID: 11351773
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Combating influenza with antiviral therapy in the pediatric population.
    Townsend KA; Eiland LS
    Pharmacotherapy; 2006 Jan; 26(1):95-103. PubMed ID: 16506351
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Neuraminidase inhibitors: zanamivir and oseltamivir.
    McNicholl IR; McNicholl JJ
    Ann Pharmacother; 2001 Jan; 35(1):57-70. PubMed ID: 11197587
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Outbreaks of influenza A and B in a highly immunized nursing home population.
    Drinka PJ; Gravenstein S; Krause P; Schilling M; Miller BA; Shult P
    J Fam Pract; 1997 Dec; 45(6):509-14. PubMed ID: 9420587
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 24.